Ingredion Inc. (INGR) – Form 144 filing: Director/officer Larry Fernandes has filed notice of intent to sell 850 common shares through Fidelity Brokerage on or after 04 Aug 2025. At the stated aggregate market value of $109,131.50, the implied share price is roughly $128.39. The proposed sale represents less than 0.002% of the 64.3 million shares outstanding and therefore is immaterial to the company’s float.
The shares were acquired via restricted-stock vesting on 11 Feb 2025; no cash was paid because the grant was compensation. In the preceding three months Fernandes sold 360 shares for $49,330.80 (≈ $137.03 per share). No other sales are disclosed in the notice. By signing the form, the filer affirms no undisclosed material adverse information and acknowledges Rule 10b5-1 obligations.
While insider sales can occasionally foreshadow sentiment shifts, the low volume and routine nature of this transaction suggest minimal market impact. Investors may nevertheless monitor future filings for any acceleration in selling activity.
Ingredion Incorporated (INGR) filed a Form 4 showing that outside director Patricia Verduin received 290 shares of common stock on 30 June 2025. The shares, valued at $137.48 each, were issued under the company’s standard annual retainer program for non-employee directors and were coded “A” (acquisition) rather than an open-market purchase. After the grant, Verduin’s direct holdings rose to 2,751 shares. No derivative securities were involved, and no other insiders were listed on the filing. Because the award is routine board compensation and represents a market value of roughly $40,000—immaterial relative to Ingredion’s market capitalization—the transaction is unlikely to influence the company’s financial outlook or share price.